Valuation (34%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.53 | -15.27 |
PEG Ratio (TTM) | 0.06 | -4.35 |
P/S Ratio (TTM) | 1.80 | 45.97 |
P/B Ratio (TTM) | 0.63 | 28.96 |
P/FCF Ratio (TTM) | -0.58 | -2.59 |
Price to 5YR AVG Earnings Ratio | -0.56 | -5.56 |
Price to 5YR AVG FCF Ratio | -0.77 | -12.33 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -64.28% | -19.06% |
ROE (TTM) | -80.13% | 15.70% |
Net Profit Margin (TTM) | -340.96% | -813.88% |
ROIC 5YR AVG | -69.97% | 3.12% |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -42.90% | -9.41% | -0.96% |
Revenue | 196.08% | 78.12% | 101.57% |
Net Income | -42.80% | -23.36% | -11.09% |
Cash Flow | -23.39% | -107.42% | -61.01% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 3.75 | 5.56 |
Quick Ratio (TTM) | 3.75 | 5.34 |
D/E Ratio (TTM) | 0.09 | 0.95 |
Interest Coverage (TTM) | -65.88 | -6.44 |
Piotroski F-Score | 3 | 5 |
Altman Z-Score | N/A | 12.45 |
LTL to 5YR AVG FCF | -0.17 | 0.11 |
Shares Outstanding Growth 5YR AVG | 10.19% | 37.46% |